JPM Healthcare Breakfast 2026
At JPM 2026, Pamir partners hosted a private breakfast with Norton Rose Fulbright, convening healthcare founders and investors around clinical proof and biology-native AI.
At JPM 2026, Pamir partners Milad Alucozai and Anand Subramanian hosted a private Builders & Backers breakfast in conjunction with Norton Rose Fulbright, convening leading healthcare founders and investors in San Francisco.
The discussion focused on clinical proof over hype, the rise of biology-native AI platforms, and the growing demand for measurable outcomes and financial discipline across biotech and digital health. The conversations kept returning to one question: which companies are building evidence, not just narrative.
